oral glp 1 weight loss Rx Trends: Real-World Data on GLP-1s for Oral GLP-1 Market to Rise
Description
Phase 2 trial data showed participants losing an average of 24.2% of body weight at the highest dose over 48 weeks
Pharmacy benefit managers (PBMs), like CVS Caremark, are constantly evaluating drugs based on their clinical effectiveness, pricing, and rebates
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS Semaglutide and Tirzepatide have been a source of disruption in the overall healthcare market
doi: 10.1371/journal.pone.0305230, 36
Both substances interact with the medication in ways worth understanding
A pragmatic trial period might be 812 weeks, during which weight, waist circumference, and any gastrointestinal symptoms should be monitored
